Product Overview

Abriva Plus tablets are a powerful combination medication used for the treatment of chronic hepatitis C virus (HCV) infection in adults. These tablets contain the active ingredients Sofosbuvir and Velpatasvir, which work together to inhibit the replication of the HCV virus in the body.

Key Benefits

• Effective treatment for chronic HCV infection
• Combination of two potent antiviral medications
• High success rates in achieving sustained virologic response
• Convenient once-daily dosing regimen

How It Works

Sofosbuvir is a nucleotide analog NS5B polymerase inhibitor, while Velpatasvir is an NS5A inhibitor. Together, these two medications work synergistically to target different stages of the HCV replication cycle, ultimately preventing the virus from multiplying and spreading in the body. This dual mechanism of action makes Abriva Plus a highly effective treatment option for patients with chronic HCV infection.

Directions for Use

• Take one tablet of Abriva Plus orally once daily with or without food
• Swallow the tablet whole with a full glass of water
• Follow the prescribed dosing schedule as instructed by your healthcare provider
• Do not miss any doses and complete the full course of treatment

Precautions

• Inform your healthcare provider about any existing medical conditions or allergies before starting Abriva Plus
• Avoid alcohol consumption while taking this medication as it may increase the risk of liver damage
• Monitor your liver function regularly during treatment
• Consult your doctor immediately if you experience any severe side effects or allergic reactions

Storage Instructions

Store Abriva Plus tablets in a cool, dry place away from direct sunlight and moisture. Keep the medication out of reach of children and pets. Do not use the tablets if the packaging is damaged or if they have expired.

Manufacturer Information

Abriva Plus tablets are manufactured by CCL Pharmaceuticals, a reputable pharmaceutical company known for producing high-quality and affordable medications for various health conditions. CCL is committed to innovation, research, and improving patient outcomes through its diverse product portfolio. Trust Abriva Plus for effective and reliable treatment of chronic HCV infection.